On January 31, 2024, Lan Industries, LLC in Miami was inspected by the Food and Drug Administration (FDA) concerning food composition, standards, labeling, and economic considerations. The company received five citations during this review, according to data posted on the FDA’s website.
The FDA website indicates that the citations were delivered to the company as follows:
- ‘You did not establish product specifications for limits on contamination that may adulterate, or that may lead to adulteration of, the finished dietary supplement.’
- ‘You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.’
- ‘Your master manufacturing record did not include a representative label, or a cross-reference to the physical location of the actual or representative label.’
- ‘You did not identify and hold components for which a material review and disposition decision is required in a manner that protects components that are not under a material review against contamination and mix-ups with those that are under a material review.’
- ‘Your quality control operations did not include reviewing and approving master manufacturing records.’
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
